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Bacterial microcompartments, BMCs, are proteinaceous organelles that encase a specific
metabolic pathway within a semi-permeable protein shell. Short encapsulation peptides can
direct cargo proteins to the lumen of the compartments. However, the fusion of such pep-
tides to non-native proteins does not guarantee encapsulation and often causes aggregation.
Here, we report an approach for targeting recombinant proteins to BMCs that utilizes specific
de novo coiled-coil protein–protein interactions. Attachment of one coiled-coil module to
PduA (a component of the BMC shell) allows targeting of a fluorescent protein fused to a
cognate coiled-coil partner. This interaction takes place on the outer surface of the BMC. The
redesign of PduA to generate an N-terminus on the luminal side of the BMC results in intact
compartments to which proteins can still be targeted via the designed coiled-coil system.
This study provides a strategy to display proteins on the surface or within the lumen of the
BMCs.
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A lthough once thought to lack subcellular organization,prokaryotes utilize a number of mechanisms to system-atically arrange cellular enzymes to both enhance meta-
bolic pathways and also to protect cellular components from
potentially damaging intermediates. Re-engineering heterologous
metabolic pathways with a higher level of organization has
become of increasing interest to synthetic biologists looking to
maximize yields from engineered pathways1. Such mechanisms
include protein-based scaffolds, DNA scaffolds, protein aggrega-
tion, and compartmentalization2–6. However, in some eubacteria,
nature has evolved small protein-based organelles called bacterial
microcompartments (BMCs) that contain a specific metabolic
pathway7. These BMCs, which are found in around 20% of
bacteria, consist of a protein shell that encases the enzymes
involved in particular metabolic pathways8–11. A recent compu-
tational study has revealed that the primary function of BMCs is
to enhance luminal intermediate concentrations leading to an
enhancement in metabolic flux12. In addition, there is convincing
evidence that BMCs protect cells from the toxicity associated with
high aldehyde concentrations13,14.
BMCs can be broadly divided into two subclasses, anabolic
carboxysomes and catabolic metabolosomes7,15. Carboxysomes
encase the enzymes carbonic anhydrase and ribulose-1,5-
bisphosphate carboxylase/oxygenase (RuBisCO) leading to high
levels of the substrate CO2 to overcome the poor catalytic activity
of RuBisCO16,17. Of the catabolic metabolosomes, the organelle
associated with 1,2-propanediol utilization (Pdu) is, to date, the
best characterized18–20. This structure, ~150 nm in diameter,
houses the enzymes required for the metabolism of 1,2-propa-
nediol (1,2-PD) via the toxic intermediate propionaldehyde to
form 1-propanol and propionyl-CoA19,21. The genetic informa-
tion encoding this metabolic module is housed on a 23-gene
operon, the so-called pdu operon19. Seven genes encode for eight
proteins that form the shell of the BMC (PduA, B, B′, J, K, N, U,
T), which either form hexameric (BMC-H), trimeric (BMC-T) or
pentameric (BMC-P) disks that assemble to form the shell22–25.
Indeed, a recent structural study has revealed the organization of
these proteins in a recombinant BMC structure, whereby the shell
proteins are orientated with their concave side facing outwards26.
Although this clearly indicates a specific orientation for the shell
proteins within a recombinant BMC, there is also evidence to
support the opposite, concave-in, arrangement in native
systems27,28.
The biotechnological potential of BMCs was first realized
through the expression of the entire pdu operon in E. coli
resulting in the formation of functional metabolosomes29. Further
work showed that through the expression of a minimal set of
BMC shell proteins (PduA, B, B′, J, K, N and U) empty BMCs
could be readily produced and isolated30. Proteins can be targeted
to such empty BMCs by fusion to short targeting sequences,
namely, D18 and P18, that are naturally found on the N-terminus
of the proteins PduD and PduP, respectively, which are integral
components of the Pdu metabolosome27,31,32. These targeting
peptides have been used to show the targeting of fluorescent
proteins to BMCs, and, more recently, they have been utilized to
construct an in vivo ethanol bioreactor4. For the latter, the
enzymes pyruvate decarboxylase and alcohol dehydrogenase have
been targeted to recombinant BMCs by fusion to the D18 and
P18 targeting peptides. The resulting strains are able to produce
more ethanol than strains producing the enzymes cytoplasmi-
cally, demonstrating that compartmentalization is beneficial to
this recombinant pathway. Other work has shown that it is
possible to utilize targeting peptides from different BMCs to
target proteins to 1,2-PD utilization BMCs. This promiscuity
suggests a relatively basic mechanism of targeting33. Indeed,
sequence analysis reveals a conserved hydrophobic motif among
BMC systems and subsequent work by Jakobson et al. shows that
it is possible to design targeting peptides de novo based on this
hydrophobic motif33,34.
Recent work has shown that fusion of the D18 and P18 tar-
geting peptides to proteins of an engineered 1,2-PD synthesis
pathway results in poor levels of protein encapsulation and
variable levels of protein aggregation3. Nonetheless, when co-
produced together these large enzyme aggregates produce sig-
nificantly more product than the untagged cytoplasmic variants.
Therefore, such active enzyme aggregates may provide an alter-
native strategy to enhance metabolic flux. However, aggregation
may be problematic if the full potential of BMCs is to be realized
and therefore alternative targeting mechanisms may facilitate the
further development of BMC technology. Towards this goal
researchers have recently used protein-interaction domains such
as PDZ, GBD and SH3 to target fluorescent proteins to recom-
binant BMCs in the host C. glutamicum35.
Here, we describe an altogether different strategy for targeting
recombinant proteins to BMCs, utilizing de novo designed coiled-
coils36,37. By attaching one half of an obligate coiled-coil het-
erodimer to the N-terminal, cytoplasm-facing region of PduA, we
demonstrate that it is possible to target to it with cargo that has
been tagged with the cognate coiled-coil partner. To target cargo
to the luminal side of the BMC, PduA was engineered so that its
N-terminus is luminal facing. This permutated version of PduA
still forms BMCs when coproduced with the other shell proteins
and the use of the heterodimeric coiled-coil peptide system then
allows for internalization of tagged cargo.
Results
Construction of coiled-coil labeled BMCs. Previously, it has
been shown that heterologous proteins can be targeted to BMCs
by fusion to short targeting peptides such as D18 or P18,
however such fusions often result in protein aggregation3,31,32.
The de novo coiled-coil peptides CC-Di-A and CC-Di-B have
been designed to interact specifically with each other and to
avoid self-association36,37. Using these peptides, we demon-
strated recently that filaments composed of a CC-Di-B-PduA*
fusion can be targeted with fusions of CC-Di-A to fluorescent
proteins such as Citrine and mCherry2. The PduA hexamers
within these filaments are also orientated with the concave side
facing outwards into the cytoplasm2,38. Therefore, we wondered
if the CC-Di-A/CC-Di-B (CC-Di-AB) cognate pairing could
also be used to target proteins to intact BMCs. To investigate
this, we generated a range of coiled-coil-PduA fusions with the
aim of incorporating the fused PduA protein into BMCs within
E. coli. To achieve this the coiled-coil peptides were fused to the
N-terminus of PduA via a glycine/serine-based linker (GS
Linker) but separated by a hexa-histidine tag and a thrombin
cleavage site (Supplementary Table 1). This led to the con-
struction of synthetic genes encoding for CC-Di-A-PduA and
CC-Di-B-PduA. The N-terminus of wild-type PduA is located
on the concave side of the hexamer and thus in assembled
recombinant BMCs faces the cellular cytoplasm26,38. Hence,
targeting to the N-terminus of PduA is presumed to append
cargo proteins to the outer surface of the organelle.
In other constructs, the sequence for a fluorescent protein
(Citrine) was incorporated between the thrombin cleavage site
and PduA to allow for the production of fluorescently labeled,
coiled-coil tagged, BMC shells (Supplementary Table 1). This
gave CC-Di-A-Citrine-PduA and CC-Di-B-Citrine-PduA. A
control construct, called C-PduA, containing the GS Linker,
hexa-histidine tag and thrombin cleavage site, but without a
coiled-coil sequence, was also made. The separate synthetic genes
for these modified PduA variants were incorporated into a
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plasmid containing the remaining genes for the other shell
proteins (PduB, B′, J, K, N, U) required to form empty BMCs. In
this way a total of six plasmids encoding CC-Di-A-PduA-U, CC-
Di-B-PduA-U, C-PduA-U, CC-Di-A-Citrine-PduA-U, CC-Di-B-
Citrine-PduA-U, and C-Citrine-PduA-U were transformed
individually into E. coli BL21 * (DE3) cells (Supplementary
Table 1). The resulting strains were grown, induced and analyzed
by transmission electron microscopy (TEM) after fixation,
embedding, thin sectioning and staining. TEM analysis revealed
the presence of BMC structures within thin sections of cells from
all six strains that were grown (Supplementary Figure 1).
The BMCs from the six strains were purified as outlined in
methods and were subjected to SDS-PAGE analysis. All of the
purified BMCs produced banding patterns typical of a BMC,
where the major bands visualized included PduB, PduB′, PduJ,
PduK and PduU. From the strains harboring CC-Di-B-PduA and
CC-Di-B-Citrine-PduA, the modified PduAs were readily dis-
cernable (Supplementary Figures 2, 3, 4). In contrast, purifica-
tions of BMCs isolated from strains producing CC-Di-A-PduA or
C-PduA did not contain a band of the expected size for PduA
suggesting that these variants are not incorporated into the BMC
shell, although it should be noted that these fusion proteins are
not as well produced by E. coli in comparison to CC-Di-B tagged
variants (Supplementary Figures 4–8).
To gain a better understanding of the structural characteristics
of the modified compartments, the purified BMCs were fixed,
embedded, thin sectioned and stained. TEM analysis revealed
closed compartments in all samples, which had outline shapes
and dimensions similar to native empty Pdu BMCs that had been
prepared and imaged in the same way. The sectioning of BMCs
randomly embedded in resin means that a range of sizes and
shapes will be observed and hence this approach does not provide
detailed analyses of the compartments (Fig. 1, Supplementary
Figures 9, 10). However, the micrographs show a number of
structures within the purified samples, which appear to be broken
BMCs. It is possible that these BMCs may have been damaged
during the purification process, which involves high-speed
centrifugation. Lipids and protein aggregates are also visualized
in purified samples, a consequence of the relatively crude
purification process.
Next, fluorescently labeled BMC variants were examined by
confocal microscopy to confirm that the modified PduAs are
incorporated into the shells of the BMCs. The strain producing
the CC-Di-B-Citrine-PduA-U BMCs contained fluorescent
puncta, indicating that CC-Di-B-Citrine-PduA is indeed incor-
porated into the BMC (Supplementary Figures 11 (B) and 12
(D)). However, strains producing CC-Di-A-Citrine-PduA-U and
C-Citrine-PduA-U do not show any such puncta, suggesting that
CC-Di-A-Citrine-PduA and C-Citrine-PduA are not incorpo-
rated into BMCs. These results are consistent with the SDS-PAGE
and western blot data, where the PduA variants are not observed
in the latter (Supplementary Figures 11 (A and C) and 12 (A and
G)).
Although PduA is a major component of the Pdu BMC it is not
essential for BMC formation in S. enterica14. This explains why
BMCs are observed in samples even though PduA variants are
not incorporated into the structure. To confirm that PduA is also
not essential for our recombinant BMC system, we constructed a
plasmid containing the genes required for BMC formation but
lacking pduA; i.e., with pduB, B’′, J, K, N and U. TEM analysis of
a b c
d e f
Fig. 1 TEM analysis of resin embedded, thin-sectioned, purified BMCs. BMCs extracted from E. coli BL21 * (DE3) cells expressing the following modified
PduA proteins. a CC-Di-A-PduA-U. b CC-Di-B-PduA-U. c C-PduA-U. d CC-Di-A-Citrine-PduA-U. e CC-Di-B-Citrine-PduA-U. f C-Citrine-PduA-U. Scale
bars show 0.2 µm
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the strain expressing PduB-U revealed correctly formed BMCs
within the cytoplasm of E. coli (Fig. 2 and Supplementary
Figure 13).
Targeting to BMCs via coiled-coil interactions. As mentioned
previously, one problem with the natural targeting peptides, D18
and P18, is that, when fused to some cargo proteins, they can
elicit protein aggregation, presumably as a result of the amphi-
pathic nature of these peptides3,27. To investigate if similar pro-
tein aggregation occurs with the coiled-coil peptides CC-Di-A
and CC-Di-B, the peptides were fused separately to the fluor-
escent protein mCherry. Cells expressing the corresponding
synthetic genes in E. coli were visualized by confocal microscopy
and TEM. With both the control (C-mCherry) and the CC-Di-A-
mCherry fusion strains a dispersed cytoplasmic fluorescence was
observed, which is indicative of a soluble protein (Supplementary
Figures 14 (A and C) and 15 (A and G). However, expression of
CC-Di-B-mCherry resulted in localized areas of increased protein
density as evidenced by fluorescent puncta in the cells and areas
of electron density in TEM micrographs, suggesting that some
self-association of the CC-Di-B-based fusion had taken place.
However, it should be noted that amorphous protein aggregates
as observed with fusions to native BMC targeting peptides were
not visible by TEM (Supplementary Figures 14 (B) and 15 (D, E
and F)).
The CC-Di-B-PduA fusion protein appears to be incorporated
into empty BMCs when co-produced with PduB, B′, J, K, N and
U. As the CC-Di-B is attached to the N-terminus of PduA, and as
the N-terminus of PduA, in the hexamer, is on the concave side of
the hexamer, evidence suggests that within the BMC the CC-Di-B
peptide will be facing into the cytoplasm of the cell26,38. To test if
the coiled-coil peptides were accessible to their cognate partner
peptide, plasmids encoding CC-Di-B-Citrine-tagged BMCs were
co-expressed with CC-Di-A-tagged mCherry. Confocal micro-
scopy revealed co-localized fluorescent puncta within the
bacterial cells, indicative of an association between the two-
tagged components. By contrast, in a control strain producing the
same CC-Di-B-Citrine-labeled BMCs and C-mCherry, the
mCherry signal remained cytoplasmic indicating no interaction
with the BMC (Fig. 3 and Supplementary Figure 16). Expression
of CC-Di-B-tagged BMCs with CC-Di-B-tagged mCherry also
resulted in co-localization of the florescence, but in this case the
areas of colocalization were large, polar and more reminiscent of
the areas of increased protein density that are observed in the
strain expressing only CC-Di-B-mCherry.
Redesign of PduA with a lumen-facing N terminus. The BMC
shell protein PduU contains the same characteristic BMC domain
as PduA, however, it is circularly permuted; i.e., the protein
secondary structure elements are identical but are arranged in a
different order, which results in the N- and C- termini being
located on opposing faces of the hexamer39,40. However, the low
occupancy of PduU in recombinant BMC shells precludes its
effective use in incorporating recombinant proteins into the BMC
lumen via coiled-coil interactions21. Therefore, we aimed to cir-
cularly permute the abundant BMC shell protein PduA to make it
analogous to PduU; i.e., to relocate the N- and C- termini to the
convex side of the hexameric disk whilst retaining the char-
acteristic BMC domain architecture41.
a b
c d
Fig. 2 Minimal requirements for BMC shell formation. TEM analyses of resin embedded, thin sectioned, E. coli BL21 * (DE3) cells (a) control strain
transformed with empty vector (b) producing the shell proteins PduA, B, B′, J, K, N and U (PduA-U) (c, d) producing the shell proteins PduB, B′, J, K, N and
U (PduB-U). c In vivo, and d from lysed cells. Scale bars show 0.2 µm
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This redesign of PduA involved moving part of the C-terminus
to the N-terminus. Based on the X-ray crystal structure of
PduA42, Val-68 was chosen as the site for the permutation; it is
exposed on the surface of the hexamer, and we hypothesized that
permutation of the segment after this residue should have
minimal effect on the structure of the hexamer. To achieve this,
the C-terminal region of PduA (GEVKAVHVIPRPHTDVEKILP)
was grafted onto the N-terminus, with a flexible linker
(GSAGSGASG) used to connect the wildtype N- and C- termini
(Fig. 4). A recent study employed a similar strategy, however, in
this case it was found that the permutation resulted in a change in
the oligomeric state of the protein from a hexamer to a pentamer,
a change that resulted in its self-assembly into a 13 nm
nanocage43.
DNA encoding the circularly permuted PduA (PduAP) was
synthesized, the gene cloned into a plasmid and transformed into
E. coli BL21 * (DE3) cells. The resultant strain was grown, and the
cells harvested, fixed, dehydrated, embedded and thin sectioned.
Subsequent analysis by TEM revealed the presence of 3 nm thick
ribbon-like structures within the cell, which often appear stacked
together in parallel (Supplementary Figure 17 (A–F)). Tomo-
graphy of these cells reveals that the ribbons extend down the full
length of the section (Supplementary Movie 1), consistent with
the ribbons representing an edge-on view of protein sheets that
have been cut transversely. Therefore, we conclude that the
ribbon-like structures represent protein sheets formed from
hexamers of PduAP. Such sheet-like structures would not form if
PduAP existed as a pentamer as has been observed with a variant
permuted PduA that had been constructed in a slightly different
way in a previous study43.
The synthetic gene encoding the PduAP was next combined in
a plasmid with the other genes required to form an empty BMC
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Fig. 3 Localization of fluorescent proteins to coiled-coil labeled BMCs. Confocal analysis of E. coli BL21 * (DE3) cells showing Citrine, mCherry and
composite fluorescence signals for cells expressing CC-Di-B-Citrine-PduA-U with CC-Di-A-mCherry, CC-Di-B-mCherry or C-mCherry. Scale bars show
2 µm
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shell (pduB, B′, J, K, N, U) generating the construct pLysS-
PduAP-U. This plasmid was transformed into BL21 * (DE3)
competent cells and analyzed by TEM as described above.
TEM revealed the presence of BMCs in vivo that were
structurally similar to empty BMCs made from wildtype proteins
(PduA-U), showing that the permutation does not have a
noticeable effect on the structure (Fig. 5A, B; Supplementary
Figure 18). In addition, BMCs are also observed free in the resin,
presumably as a result of some cell lysis, and are morphologically
similar to their wildtype PduA-containing counterparts (Fig. 5C,
D; Supplementary Figure 18), providing further evidence that the
circular permutation does not affect the structure of BMCs.
However, attempts to purify BMCs containing PduAP, using the
previously well-established extraction procedures, failed. Pre-
sumably, this is because incorporation of PduAP into BMCs
changes their solubility characteristics. To demonstrate that
PduAP is incorporated into the BMCs in vivo, a fluorescent
version of PduAP was constructed integrating the CC-Di-B-
Citrine module onto its N-terminus. Confocal microscopy of the
strain producing this CC-Di-B-Citrine-PduAP-U complex
revealed florescent puncta, consistent with this fusion being
successfully incorporated into the BMC shell (Supplementary
Figures 19 B and 20 D). In contrast, strains expressing CC-Di-A-
Citrine-PduAP-U or C-Citrine-PduAP-U did not have a punctate
fluorescent phenotype suggesting that these variants are not
incorporated into the shell of the BMC as seen with the non-
permuted variants (Supplementary Figures 19 (A and C) and 20
(A and G)).
Targeting to BMCs containing PduAP. To investigate targeting
to PduAP, we utilized the same CC-Di-AB system used with
PduA36,37. Addition of CC-Di-B to PduAP, and in the presence
of PduB-U, did not disrupt BMC formation (Supplementary
Figure 21). However, we noted that some malformed BMCs
were present in these strains, but only to a similar level as
observed for the unmodified empty shell construct (PduA-U)
(Supplementary Figures 10 and 21). BMCs that appeared to
have been released through cell lysis offered better visualization
of the structures, and these were morphologically similar to the
unmodified control (PduA-U) and to permuted BMCs lacking
the coiled-coil sequence (Figs. 5, 6 and Supplementary
Figure 22).
Next, we sought to target cargo protein to the coiled-coil tagged
PduAP within the BMC. Strains were transformed with a plasmid
encoding CC-Di-B-Citrine-PduAP-U and a second plasmid
producing the fluorescent protein reporter (mCherry) tagged
with either CC-Di-A, CC-Di-B or lacking a coiled-coil sequence
(C-mCherry). Strains were grown and analyzed by confocal
fluorescence microscopy (Fig. 7 and Supplementary Figure 23).
Co-localized fluorescence signals were apparent in the strain
expressing CC-Di-B-Citrine-PduAP-U and CC-Di-A-mCherry,
although it must be noted that a high amount of cytoplasmic CC-
Di-A-mCherry was also present, suggesting that not all of the
protein is targeted to the BMC (lumen). A wholly cytoplasmic
mCherry signal was observed in the strain producing CC-Di-B-
Citrine-PduAP-U together with untagged mCherry (C-mCherry)
(Fig. 7). Together, these results provide strong evidence that it is
possible to utilize de novo designed coiled-coil peptides to target
to the luminal side of BMCs.
Discussion
Previously, we have shown that a de novo designed and highly
specific coiled-coil peptide pair, termed CC-Di-A and CC-Di-B,
can be used to target proteins to filamentous tubules formed in
the cytoplasm of E. coli. These tubules, which we collectively call a
cytoscaffold, are formed by the overproduction of a soluble form
a b c
d
Fig. 4 Circular permutation of the shell protein PduA. a Computationally generated model of our permuted PduA (PduAP) generated with Phyre245
(magenta) overlaid with the native structure (blue) with the flexible linker joining the native N- and C- termini highlighted in green. b, c Architecture of the
native PduA hexamer 3NGK [http://dx.doi.org/10.2210/pdb3ngk/pdb] (blue) illustrating the permuted variant PduAP (magenta). N- and C- termini are
highlighted in red and orange respectively in (a, b) and c. d Methodology for creating a circularly permuted PduA with the transplanted region highlighted
in red and the linker region in green
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05922-x
6 NATURE COMMUNICATIONS |  (2018) 9:3413 | DOI: 10.1038/s41467-018-05922-x | www.nature.com/naturecommunications
of the natural BMC protein PduA, termed PduA*2. With this
system, we find that CC-Di-B-PduA* filaments bind protein
cargoes tagged with CC-Di-A, results that are consistent with the
N-terminus of PduA* facing the cellular cytoplasm.
Therefore, and as detailed herein, we wondered if the same
coiled-coil system could be used to direct cargo to an empty
recombinant BMC within E. coli. Such BMCs are formed from
the coordinated production of multiple shell proteins, PduA-U.
To achieve our goal, we investigated the effect of adding CC-Di-A
or CC-Di-B to the N-terminus of wildtype PduA and co-
producing these variants with the remaining shell proteins. We
find that only the CC-Di-B-PduA variant incorporates into the
recombinant BMCs. It appears that CC-Di-A makes the PduA
unstable, which is also what we observe for tagged versions of
PduA*2.
By coproducing CC-Di-B-PduA with PduB-U, intact BMCs are
observed by TEM. Similar BMCs are also observed for a CC-Di-
B-Citrine-PduA version produced with PduB-U. In this case, the
presence of BMCs was additionally confirmed by confocal
microscopy, which reveals fluorescent puncta within the cellular
cytoplasm. The ability of the CC-Di-A peptide to bind to the CC-
Di-B-PduA variants was demonstrated in vivo with a CC-Di-A-
mCherry fusion protein where co-production of the latter with
the BMC containing the CC-Di-B-Citrine-PduA gives co-
localized puncta within cells. In these cases, on the basis of the
X-ray crystal structure of PduA and further recent experimental
evidence including the structure determination of a recombinant
BMC as well as regiospecific imaging of PduA filaments and
targeted proteolysis of PduA fusions within BMCs, we suggest
that the mCherry is being directed to the outer, cytoplasm-facing
side of these recombinant BMCs26,38.
However, it should be noted that there still remains some
ambiguity over the orientation of shell proteins in native BMCs
with some evidence suggesting interactions between luminal
enzymes and the concave faces of shell proteins, indicative of the
concave face being luminal27,28. Conversely, in recombinant
systems, including the system used here, evidence points towards
the concave face being cytoplasmic26,38. For the purposes of this
research we are working on the assumption that the N- and C-
terminii of PduA are located on the concave outward-facing side
of the protein.
Therefore, and following on from this, we speculated the
coiled-coil peptides could be used to target to the luminal side of
the BMC through the redesign of PduA to relocate the N-
terminus to the convex side of the hexamer. To achieve this, we
permutated PduA after residue 68 to maintain its overall structure
by moving the N- and C- termini to the opposite side of the
molecule. This permutated form of PduA, PduAP, forms
recombinant BMCs in vivo when co-produced with PduB-U,
although these could not be recovered for detailed in vitro ana-
lysis, suggesting that the PduAP changes the physical properties of
the BMC in some way.
Nonetheless, both CC-Di-B and CC-Di-B-Citrine can be fused
to PduAP to render competent recombinant BMCs. Indeed, the
co-production of CC-Di-B-Citrine-PduAP with PduB-U gives
fluorescent puncta within the cells, consistent with the incor-
poration of PduAP into the BMC. Again, targeting to the CC-Di-
B-PduAP-containing BMCs was demonstrated with a CC-Di-A-
mCherry fusion and the co-localization of Citrine and mCherry
signals. These results are consistent with our objective of incor-
porating cargo protein within the lumen of the BMC using coiled-
coil technology.
a b
c d
Fig. 5 Expression of circularly permuted BMCs. TEM analyses of resin embedded, thin sectioned, E. coli BL21 * (DE3) cells producing wild type PduA BMCs
and circularly permuted PduAP BMCs. a, c PduA-U in-vivo and isolated (b, d) PduAP-U. Scale bars show 0.2 µm
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In summary, we have developed methods for the localization of
proteins to both the outside and the inside of BMCs. Targeting to
the outside could be used to display proteins on a comparatively
large protein framework, for example, in the generation of anti-
bodies. The internal accommodation of proteins can be used to
engineer new metabolic pathways within the BMC; such endowed
BMCs could be used as delivery vehicles. Through these
approaches we have shown that the field of cellular and metabolic
engineering depends not only on the implementation of natural
architectures but also on de novo design, in order to achieve
maximal functionality.
Methods
Cloning of constructs. DNA was synthesized by Eurofins Genomics, sequence
information is shown in Supplementary Data 1, 2 and 3. Plasmids were constructed
as outlined in Supplementary Table 1 and Supplementary Data 4 with primers
listed in Supplementary Table 2. JM109 competent cells were used for all cloning
steps (Supplementary Table 3).
Growth of strains producing BMCs. BL21* (DE3) competent cells were trans-
formed with appropriate plasmids. LB (50 mL) supplemented with ampicillin
(100 mg/L) and chloramphenicol (34 mg/L) in baffled flasks was inoculated from
an overnight starter culture. Cells were grown at 37 °C with shaking to an
OD600 ∼ 0.4, protein production was induced by addition of IPTG to a final
concentration of 400 µM. Cultures were incubated for 2 h at 19 °C with shaking
for confocal and TEM analysis or overnight with shaking for TEM analysis and
purification.
Cell lysis. Cells were harvested by centrifugation at 2683 × g, a one gram wet cell
pellet was resuspended in 20 mL Yeast Protein Extraction Reagent (Y-PER) sup-
plemented with protease Inhibitor Cocktail Tablets, EDTA-Free and 500 Units
benzonase nuclease and incubated for 3 h at room temperature with gentle shaking.
Purification of CC-Di-B tagged BMCs. BMCs were pelleted from the lysate by
centrifugation for 5 min at 11,300 × g, the pellet was resuspended in 2 mL 20mM
Tris-HCl pH 8, 20 mM NaCl. The suspension was centrifuged at 4 °C for 5 min at
11,000 × g. The BMC containing pellet was resuspended in 2 mL 20 mM Tris-HCl
pH 8 and centrifuged for 5 min at 11,000 × g, the BMC containing supernatant was
collected and the NaCl concentration was increased to 80 mM. The suspension was
centrifuged as above. The pellet was resuspended in an appropriate volume of
20 mM Tris-HCl pH 8 for analysis.
Purification of CC-Di-A tagged and untagged BMCs. BMCs were pelleted from
the lysate by centrifugation for 5 min at 11,300 × g, the pellet was resuspended in
2 mL of 20 mM Tris-HCl, pH 8, containing 20 mM NaCl. The suspension was
centrifuged at 4 °C for 5 min at 11,000 × g. The supernatant, containing micro-
compartments was collected; the NaCl concentration was increased to 80 mM. The
suspension was centrifuged at 4 °C for 5 min at 11,000 × g, the resulting pellet
contained BMCs.
Western blot analysis. Following transfer and blocking nitrocellulose membranes
were incubated in primary antibody (mouse anti-His (Sigma-Aldrich; catalog
#H1029; diluted 1:3000 in PBS)) for 2 h. Membranes were washed three times in
PBS then equilibrated for 10 min in 50 mM Tris-HCl pH 7.5, 150 mM NaCl.
Membranes were then incubated in a secondary antibody coupled to alkaline
phosphatase (Anti-Mouse IgG (H+ L), AP Conjugate (Promega; catalog #S3721;
diluted 1:5000 in 50 mM Tris-HCl pH 7.5, 150 mM NaCl)). Bands were visualized
by incubation in substrate 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tet-
razolium (BCIP/NBT).
Embedding of samples for TEM analysis. Following growth and induction of
protein expression cells were harvested by centrifugation at 3000 × g. For
embedding of BMCs the final pellet from the purification was used in place of a
cell pellet. Pellets were fixed in 2 ml 2.5% glutaraldehyde in 100 mM sodium
cacodylate buffer pH 7.2 (CAB) and incubated for 2 h with gentle rotating. Cells/
BMCs were pelleted by centrifugation at 6000 × g for 2 min and were washed
twice with 100 mM CAB for 10 min. Cells were stained with 1% osmium tetr-
oxide in 100 mM CAB for 2 h and then washed twice with ddH2O prior to
a b c
d e f
Fig. 6 TEM analysis of coiled-coil tagged circularly permuted BMCs. BMCs tagged with coiled-peptides from lysed E. coli BL21 * (DE3) cells expressing the
following modified PduA proteins. a CC-Di-A-PduAP-U. b CC-Di-B-PduAP-U. c C-PduAP-U. d CC-Di-A-Citrine-PduAP-U. e CC-Di-B-Citrine-PduAP-U. f C-
Citrine-PduAP-U. Scale bars show 0.2 µm
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dehydration. Dehydration was carried out by incubation in an ethanol gradient,
50% EtOH for 10 min, 70% EtOH overnight, 90% EtOH for 10 min, 100% dry
EtOH for 10 min 3 times. Pellets were washed twice with propylene oxide for
15 min. Samples were embedded by first washing in 1 ml of a 1:1 mix of pro-
pylene oxide and Agar LV Resin for 30 min with rotation and then by suspen-
sion in freshly prepared 100% Agar LV resin twice for 1.5 h. The pellet was re-
suspended in fresh resin and transferred to a 1 ml Beem embedding capsule
(size 00) and subsequently centrifuged for 5 min at 3000 × g to concentrate the
cells to the tip of the mold. Polymerization was achieved by incubation at 60 °C
for 20 h.
Sectioning and visualization of samples. Following embedding samples were
ultra-thin sectioned on a RMC MT-XL ultra-microtome with a diamond knife
(diatome 45°) thin sections (60–70 nm) were collected on un-coated 300 mesh
copper grids. Grids were first stained by incubation in 4.5% uranyl acetate in 1%
acetic acid for 45 min followed by washing for 10 s in a stream of ddH2O to remove
any excess stain. Grids were subsequently stained with Reynolds lead citrate for
7 min followed by washing in a stream of ddH2O.
Sections were observed and photographed using a JEOL-1230 transmission
electron microscope equipped with either a Gatan multiscan or Gatan OneView
digital camera operated at an accelerating voltage of 80 kV.
Confocal imaging. Following growth and induction of protein expression 1 ml of
cells were harvested by centrifugation at 3000 × g. The cell pellet was washed in PBS
three times then fixed in 2% (w/v) formaldehyde in PBS 15 min, cells were sub-
sequently washed a further 3 times in PBS. Cells (10 μL) were pipetted onto a 1.5
thickness coverslip (0.17 ± 0.005 mm) before being inverted onto a drop of Pro-
Long Gold antifade mountant (Life Technologies) on a glass slide. Samples were
cured for 24 h in the dark prior to imaging.
Images were acquired on a Zeiss LSM 880 with Airyscan system. Excitation
light (514 nm for Citrine or 561 nm for mCherry) was provided by an argon laser
(514 nm) or HeNe Laser (561). Images were acquired using a 100 × 1.46 NA oil
immersion objective lens.
Tomography. Sections (250 nm) were cut from existing blocks, and 15 nm gold
fiducials (Aurion, TomoSol solution) were applied to both sides of the sections.
Sections were imaged using a Tecnai 20 TEM (FEI, the Netherlands) operated at
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Fig. 7 Localization of fluorescent proteins to circularly permuted coiled-coil labeled BMCs. Confocal analysis of E. coli BL21 * (DE3) cells showing Citrine,
mCherry and composite fluorescence signals for cells expressing CC-Di-B-Citrine-PduAP-U in conjunction with CC-Di-A-mCherry, CC-Di-B-mCherry or C-
mCherry. Scale bars show 2 µm
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200 kV and tilt series images were acquired between –66° to+ 66° with 1.5° (above
45°) and 2° increments (below 45°). Images were acquired on a 4k by 4k FEI Eagle
camera with a pixel size of 1.38 nm. The resulting tomograms were reconstructed
and combined using IMOD software44.
Data availability. All data, including images and clones, are available upon request
from the authors.
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